Sentence examples for in responsiveness from from inspiring English sources

Changes in responsiveness from before detection learning until after discrimination learning were stronger at control locations than at target locations.

2. Sensitizers, following their increase in responsiveness from trial 1 to trial 2 (which was the basis of their selection), show a dramatic decrease in response magnitude from trial 2 to trial 3 in all four effector systems.

To determine whether altered protein acetylation could account for the switch in LIF responsiveness from normal to carcinoma cells, the normal epithelial cells were treated for 6 h with the histone deacetylase inhibitor FR901228.

It is possible that these differences in responsiveness might result from differences in cell passage number, because similar in-vitro aging effects were shown previously [ 53].

To test whether ChR2-tagged PV-positive neurons differed in their auditory responsiveness from nearby untagged neurons selected randomly, we assessed the neural response elicited in each population by white noise bursts.

Finally, to test whether ChR2-tagged callosally-projecting neurons differed in their auditory responsiveness from nearby untagged neurons selected randomly, we assessed the neural response elicited in each population by white noise bursts.

Exploratory analysis revealed that the dyspareunia group did not differ in their genital responsiveness from controls.

(2) Whereas women with dyspareunia did not differ in their genital responsiveness from sexually functional women, they reported overall higher levels of negative affect to the erotic stimulus.

The change in influence of PMv on M1 can also be understood as a change in responsiveness of M1 to input from PMv. PPI analysis requires an a priori hypothesis about directionality; from physiological models it is well established that PMv provides a major input into M1 (Dum and Strick, 2005).

Taken together, our findings demonstrate a difference in responsiveness to TNF between EC derived from CM patients and those derived from UM patients.

Are there, aside from rituximab, differences in responsiveness to bDMARDs between seropositive and seronegative patients?